MDS
Clinical trials for MDS explained in plain language.
Never miss a new study
Get alerted when new MDS trials appear
Sign up with your email to follow new studies for MDS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood cancer treatment showdown: two drug combo vs. single therapy
Disease control OngoingThis study is looking at which treatment works better for people with higher-risk forms of two blood disorders called MDS and CMML. Researchers are comparing a two-drug combination (venetoclax plus HMAs) against just the HMAs drug alone. They're reviewing medical records of 224 p…
Matched conditions: MDS
Sponsor: Guangdong Provincial People's Hospital • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New hope for rare blood cancers: drug trial aims to shrink spleens and ease suffering
Disease control OngoingThis study is testing if the drug fedratinib is effective and safe for people with rare, hard-to-treat blood cancers. It will involve about 25 adults with specific conditions like MDS/MPN or chronic neutrophilic leukemia. The main goal is to see if the drug can control the diseas…
Matched conditions: MDS
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New attack plan for blood Cancer's comeback
Disease control OngoingThis study is testing a combination of two drugs (venetoclax and azacitidine) along with an infusion of immune cells from the original stem cell donor. It is for adults whose myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) has come back after a stem cell transplant…
Matched conditions: MDS
Phase: PHASE1, PHASE2 • Sponsor: Groupe Francophone des Myelodysplasies • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New drug targets hidden leukemia cells in patients who failed standard care
Disease control OngoingThis study tests an experimental drug called vibecotamab in adults with two types of blood cancer: acute myeloid leukemia (AML) that still shows tiny amounts of cancer after treatment, and myelodysplastic syndrome (MDS) that has stopped responding to standard medications. The goa…
Matched conditions: MDS
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC